Powered by

Former CEO pleads guilty to fentanyl spray kickback scheme

Jan 09, 2019 - Associated Press Financial Wire

BOSTON (AP) - The former chief executive of a company that produces a potentially addictive fentanyl spray pleaded guilty Wednesday to scheming with his colleagues to bribe doctors into increasing prescriptions to boost sales.

Former Insys Therapeutics CEO Michael Babich also agreed to cooperate with federal prosecutors who are preparing to go to trial in Boston later this month against the Chandler, Arizona-based company's wealthy co-founder, John Kapoor, and other executives.